Advertisement
more top stories »

Drugs


— Health and Wellbeing

"Compound 14" mimics the effects of exercise without setting foot in the gym

By - July 27, 2015 1 Picture

Enjoying the health benefits of a back-breaking workout without actually working out sure is a tantalizing prospect. This goes a long way to explaining the torrent of exercise equipment that promises to do more for our figures with less of our sweat and tears, and recently, the development of drugs that could imitate the beneficial effects of exercise. The latest advance in this area is the development of a molecule that mimics the effects of exercise by influencing the metabolic process, giving it the potential to treat type 2 diabetes and obesity.

Read More
— Games

Esports organizers to clamp down on performance-enhancing drug use

By - July 27, 2015 1 Picture

Its competitors might not be faced with the exhausting mountain climbs of the Tour de France or the rigors of Major League Baseball, but that doesn't mean professional video gaming is free from the grip of doping in sports. The world's largest esports organization ESL, which hosts a US$250,000 Counter-Strike tournament in Germany next month, is partnering with anti-doping authorities to clamp down on gamers resorting to performance-enhancing drugs (PEDs) to gain an edge.

Read More
— Health and Wellbeing

Is a breath test for marijuana nothing but a pipe dream?

By - July 15, 2015 2 Pictures

Difficulties in testing for THC mean that curbing cannabis use amongst drivers hasn't been all that straightforward. Though marijuana use can be detected in the saliva for up to 24 hours after use, it can show up in blood and urine samples for anywhere up to a month. Existing methods like blood and urine samples therefore make it hard to determine whether a driver is actually impaired at the time that they jump behind the wheel. But companies like Canada's Cannabix are working on portable breathalyzers designed to test exclusively for recent use of the drug, a solution that could be of great assistance to law enforcement personnel in keeping impaired drivers off the road.

Read More
— Medical

FDA ticks off first drug to treat radiation sickness after nuclear disasters

By - May 25, 2015 1 Picture

A drug long-used to counter the negative effects of chemotherapy has won US Food and Drug Administration (FDA) approval for use in treating the nasty effects of exposure to radiation following a nuclear disaster. Known commercially as Neupogen, the drug has been shown to work by shielding the body's white blood cells to heighten a patient's chances of survival.

Read More
— Medical

Magnetic nanoparticles open blood-brain barrier for delivery of therapeutic molecules

By - March 26, 2015 1 Picture
The blood-brain barrier is a highly selective semipermeable barrier running inside almost all vessels in the brain that lets through water, some gases and a few other select molecules, while preventing potentially toxic elements in the blood from entering the brain. Researchers from the University of Montreal, Polytechnique Montréal, and CHU Sainte-Justine say that currently 98 percent of therapeutic molecules are also blocked by the barrier, but they have developed a technique using magnetic nanoparticles that opens the door for such molecules, thereby also opening the door to new treatments for brain diseases. Read More
— Robotics

"Robot scientist" Eve to save time and money in drug development

By - February 7, 2015 1 Picture
Modern pharmaceuticals are a wonder of our age, but they also take years to develop at incredible cost. To shorten development time and increase economy, scientists at the Universities of Cambridge and Manchester have built Eve, an artificially-intelligent "robot scientist" that is not only faster and cheaper than its human counterparts, but has already identified a compound that could be used to fight malaria. Read More
— Medical

Newly-discovered compound gives hope in fight against antibiotic-resistant bacteria

By - January 8, 2015 1 Picture
Over the past quarter century, many pharmaceutical companies have largely turned their backs on the quest to develop new antibiotics, blaming difficulties surrounding the clinical trials process and turning their attention to the more profitable development of so-called "lifestyle drugs." One company bucking the trend is NovoBiotic Pharmaceuticals, which has announced the discovery of a new class of antibiotic that holds promise for treating drug-resistant superbugs. Read More
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement